Filing Details
- Accession Number:
- 0001209191-19-012005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-21 16:26:09
- Reporting Period:
- 2019-02-19
- Accepted Time:
- 2019-02-21 16:26:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1661567 | Michael Parini | 50 Northern Avenue Boston MA 02210 | Evp, Cl&Ao | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-02-19 | 4,624 | $186.79 | 36,003 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-19 | 600 | $187.42 | 35,403 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-19 | 400 | $188.54 | 35,003 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $186.79 (range $186.09 to $187.05).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $187.42 (range $187.12 to $187.96).
- Open market sales reported on this line occurred at a weighted average price of $188.54 (range $188.36 to $188.85).